SNSF
Investigator Initiated Clinical Trials (IICT)
Full proposal due 3 November 2026, 17:00 Swiss local time. Letter of intent due 26 May 2026, 17:00 Swiss local time (past). PPI Preparatory Grant application also due 26 May 2026.
Last updated:
The SNSF Investigator Initiated Clinical Trials programme funds randomised controlled trials (RCTs) addressing unmet medical and societal needs, with project duration up to five years plus an optional one-year preparation phase. Applicants must be based at eligible Swiss institutions and lead a multicentric trial with a research team of up to five persons. The call requires patient and public involvement documentation and excludes pilot studies, observational designs, and industry-driven trials.
Details
| Funder | SNSF |
| Budget | Not specified (PPI Preparatory Grant up to CHF 5,000 separately available) |
| Deadline | 3 November 2026 |
| Duration | Up to 5 years |
| Consortium | Required — research group of up to 5 persons in a multicentric setting; recruiting centres must confirm participation in writing |
| Application | 2-stage: letter of intent (26 May 2026) → full proposal (3 November 2026) |
| Frequency | Annual |
| Eligible countries | CH |
Eligibility & scope
Supports randomised controlled clinical trials (RCTs) of high scientific quality addressing unmet medical/societal needs, not in industry focus. Applicants must be natural persons meeting SNSF eligibility requirements, affiliated with Swiss institutions, forming a research group. Excludes pilot, proof-of-concept, observational, and preclinical studies. Patient and public involvement (PPI) is required. A PPI preparatory grant of up to CHF 5,000 is available alongside the letter of intent.
Who Should Apply
- •Researchers based at eligible Swiss institutions
- •Clinical investigators leading or co-leading a multicentric RCT
- •Trials addressing unmet medical or societal needs with patient relevance
- •Research teams of up to five persons with commitment to patient and public involvement
Key Dates
- •Letter of intent due 26 May 2026, 17:00 Swiss time (two-stage application)
- •Full proposal due 3 November 2026, 17:00 Swiss time
- •Project duration up to five years, with optional 12-month preparation phase
Tips for Applicants
- ✓Patient and public involvement (PPI) documentation is mandatory, plan and budget this explicitly in your proposal.
- ✓The multicentric requirement is gating; single-site trials are ineligible regardless of design quality.
- ✓Industry cannot be the driver of the research question, but industry partnerships on defined terms are permitted; clarify roles upfront.
Frequently Asked Questions
What types of clinical trials does SNSF support under this call?
Randomised controlled trials (RCTs) addressing unmet medical or societal needs. Pilot, proof-of-concept (phase I/IIa), observational, and industry-driven studies are excluded.
How long can an SNSF Investigator Initiated Clinical Trial project last?
Up to five years, with an optional preparation phase of up to 12 months.
Do I need a multicentric setting for SNSF Investigator Initiated Clinical Trials?
Yes, a multicentric setting is a mandatory requirement for all proposals.
Can non-Swiss researchers apply for SNSF Investigator Initiated Clinical Trials?
No, applicants must be based at eligible Swiss institutions to be eligible.
Related on Grantsby
- SNSF writing tips & FAQ
Evaluation criteria, proposal structure, common mistakes.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
Similar grants
Clinical Research
FWFPipeline
KWFDeadline: 8 Dec 2026€1M–€2.5M (Phase I/I-II); €1M–€5M (Phase II/III)EJP Rare Diseases
SNSFEME Programme Researcher-Led
NIHRClinical Research Funding Scheme
Cancer Research UKDeadline: 3 Dec 2026Flexible; module dependent
Browse Related
Could Investigator Initiated Clinical Trials (IICT) be right for you?
See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →